English
|
Español
English
|
Español
Insurance
Marketing
Pharmaceuticals
Technology/Innovation
Regulatory
Community
Horizon Pharma
Robert Hadley
| Jun 17, 2017
U.S. court sides with Horizon Pharma in patent infringement claim regarding Pennsaid
Chandra Lye
| May 4, 2017
FDA approves use of Ravicti to treat urea cycle disorders in younger pediatric patients
Ruth de Jauregui
| Mar 31, 2017
Horizon Pharma presents new data on Ravicti
Gene Johnson
| Mar 24, 2017
Horizon Pharma launches initiative for people with rare genetic disease
Jireh Gibson
| Mar 19, 2017
Horizon Pharma launches initiative to raise awareness of people affected by rare diseases
Trending
+
Regulatory
C.D. Marsden
| Apr 12, 2025
Empower Pharmacy: Eli Lilly lawsuit is ‘Big Pharma’s attempt to limit patient and provider choice’
+
Pharmaceuticals
Patient Daily
| Apr 10, 2025
Researchers uncover mechanisms behind metabolic demands in nursing mothers
+
Pharmaceuticals
Patient Daily
| Apr 15, 2025
UCSF neurosurgeon: '340B is a drug discount program that hospitals exploit as an additional revenue stream'
+
Pharmaceuticals
Patient Daily
| Apr 15, 2025
Former Domestic Policy Council director: 340B program turns large non-profit hospitals into 'pure profit' centers
